Target
5-HT3 receptor
1 product, 1 indication
Indications
chemotherapy-induced nausea and vomiting (1 products)
Loading...
1 drug
5 abstracts
Abstract
An Indian real-world experience of intravenous fosnetupitant-palonosetron (IV NEPA) in preventing delayed and extended delayed CINV.Org: Glenmark Pharmaceuticals Ltd, Delhi State Cancer Institute, Jawaharlal Nehru Cancer Hospital and Research Centre, Hanji Cancer Hospital, Lakshya Cancer Hospital and Research Centre,
Abstract
Guideline-concordant use of olanzapine as part of a 4-drug antiemetic regimen for high emetic risk chemotherapy across the state of Michigan.Org: Michigan Oncology Quality Consortium, University of Michigan,
Abstract
Cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: Results of a phase II/III, placebo-controlled, randomised trial.Org: NHMRC Clinical Trials Centre, The University of Sydney, Northern Beaches Hospital, University of Adelaide, Campbelltown Hospital,
Abstract
Real-world analysis of cardiac, gastrointestinal, and hematologic toxicities between commonly used antiemetics in everyday oncology clinical practice.Org: Louisiana State University in Shreveport, Feist-Weiller Cancer Center at LSUHSC-Shreveport, LSU Health Shreveport,
Abstract
Risk of malnutrition and predisposing factors among Mexican patients with advanced cancer.Org: Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México City, Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán, Mexico City, Mexico, Mexico City, DF, Mexico, DFCI/PCC Fellowship Program - Attendings,